Michael D. Tsifansky

673 total citations
14 papers, 518 citations indexed

About

Michael D. Tsifansky is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Biomaterials. According to data from OpenAlex, Michael D. Tsifansky has authored 14 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 2 papers in Biomaterials. Recurrent topics in Michael D. Tsifansky's work include Inhalation and Respiratory Drug Delivery (5 papers), Cystic Fibrosis Research Advances (5 papers) and Neonatal Respiratory Health Research (2 papers). Michael D. Tsifansky is often cited by papers focused on Inhalation and Respiratory Drug Delivery (5 papers), Cystic Fibrosis Research Advances (5 papers) and Neonatal Respiratory Health Research (2 papers). Michael D. Tsifansky collaborates with scholars based in United States, China and South Korea. Michael D. Tsifansky's co-authors include Yoon Yeo, Yan Yang, Peisheng Xu, Yan Yang, Sooyoung Shin, Simseok A. Yuk, Gudrun Schmidt, Chia‐Jung Wu, L. Tiffany Lyle and Oleg V. Evgenov and has published in prestigious journals such as Biomaterials, Scientific Reports and CHEST Journal.

In The Last Decade

Michael D. Tsifansky

13 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Tsifansky United States 9 284 149 94 90 84 14 518
Andreas Henning Germany 9 244 0.9× 347 2.3× 134 1.4× 69 0.8× 69 0.8× 9 619
Takehisa Nakajima Japan 14 337 1.2× 378 2.5× 83 0.9× 72 0.8× 153 1.8× 20 700
Mohamed Gaber Egypt 11 182 0.6× 125 0.8× 226 2.4× 138 1.5× 162 1.9× 37 729
Esmaeil Moazeni Iran 10 167 0.6× 281 1.9× 95 1.0× 33 0.4× 84 1.0× 15 485
Ankur Sharma India 17 142 0.5× 126 0.8× 139 1.5× 141 1.6× 152 1.8× 36 651
Concetta Giovino Italy 8 180 0.6× 303 2.0× 82 0.9× 44 0.5× 110 1.3× 9 493
Ayca Yıldız-Peköz Türkiye 13 125 0.4× 144 1.0× 97 1.0× 49 0.5× 58 0.7× 23 460
Mohamed Ehab Ali Germany 10 124 0.4× 158 1.1× 95 1.0× 72 0.8× 85 1.0× 11 436
Nancy M. Elbaz United Kingdom 10 119 0.4× 119 0.8× 94 1.0× 139 1.5× 180 2.1× 12 539
Sharif Abdelghany Jordan 10 132 0.5× 327 2.2× 84 0.9× 97 1.1× 109 1.3× 16 545

Countries citing papers authored by Michael D. Tsifansky

Since Specialization
Citations

This map shows the geographic impact of Michael D. Tsifansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Tsifansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Tsifansky more than expected).

Fields of papers citing papers by Michael D. Tsifansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Tsifansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Tsifansky. The network helps show where Michael D. Tsifansky may publish in the future.

Co-authorship network of co-authors of Michael D. Tsifansky

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Tsifansky. A scholar is included among the top collaborators of Michael D. Tsifansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Tsifansky. Michael D. Tsifansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Tetz, George, et al.. (2023). AtbFinder Diagnostic Test System Improves Optimal Selection of Antibiotic Therapy in Persons with Cystic Fibrosis. Journal of Clinical Microbiology. 61(1). e0155822–e0155822. 3 indexed citations
2.
Tetz, George, et al.. (2022). Treatment of chronic relapsing urinary tract infection with antibiotics selected by AtbFinder. Urology Case Reports. 46. 102312–102312. 5 indexed citations
3.
Yuk, Simseok A., Hyungjun Kim, Nader S. Abutaleb, et al.. (2021). Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis. Science Advances. 7(32). 46 indexed citations
4.
Yuk, Simseok A., et al.. (2018). Recent Advances in Nanomedicine for Sepsis Treatment. Therapeutic Delivery. 9(6). 435–450. 30 indexed citations
5.
Hyun, Hyesun, Seika Hashimoto‐Hill, Myunghoo Kim, et al.. (2017). Succinylated Chitosan Derivative Has Local Protective Effects on Intestinal Inflammation. ACS Biomaterials Science & Engineering. 3(8). 1853–1860. 19 indexed citations
6.
Cho, Eun Jung, Kyung‐Oh Doh, Jinho Park, et al.. (2016). Zwitterionic chitosan for the systemic treatment of sepsis. Scientific Reports. 6(1). 29739–29739. 15 indexed citations
7.
Pins, Michael, et al.. (2014). Successful Therapy of Rapidly Progressing Bronchiolitis Obliterans in an Adolescent. CHEST Journal. 146(4). 691A–691A. 1 indexed citations
8.
Tsifansky, Michael D., et al.. (2013). 1173. Critical Care Medicine. 41. A298–A298. 6 indexed citations
9.
Tsifansky, Michael D., et al.. (2011). Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease. Expert Opinion on Drug Delivery. 8(4). 451–466. 29 indexed citations
10.
11.
Yang, Yan, et al.. (2010). Mannitol‐Guided delivery of ciprofloxacin in artificial cystic fibrosis mucus model. Biotechnology and Bioengineering. 108(6). 1441–1449. 67 indexed citations
12.
13.
Yang, Yan, et al.. (2009). Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 30(10). 1947–1953. 220 indexed citations
14.
Tsifansky, Michael D., Yoon Yeo, Oleg V. Evgenov, et al.. (2008). Microparticles for Inhalational Delivery of Antipseudomonal Antibiotics. The AAPS Journal. 10(2). 254–60. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Henning Breakdown of academic impact, for papers by Takehisa Nakajima Breakdown of academic impact, for papers by Mohamed Gaber Breakdown of academic impact, for papers by Esmaeil Moazeni Breakdown of academic impact, for papers by Ankur Sharma Breakdown of academic impact, for papers by Concetta Giovino Breakdown of academic impact, for papers by Ayca Yıldız-Peköz Breakdown of academic impact, for papers by Mohamed Ehab Ali Breakdown of academic impact, for papers by Nancy M. Elbaz Breakdown of academic impact, for papers by Sharif Abdelghany
Rankless by CCL
2026